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THE work described in this paper was carried out as a preliminary study on
the " viability" of Ehrlich ascites tumour cells. Several tests have been
described, using stains, which purport to distinguish "viable" from "non-
viable" cells. However Hoskins, Meynell and Sanders (1956), using the ascites
form of the Krebs-2 carcinoma, have pointed out that the results of such tests
are not clearly related to the ability of tumours to grow in susceptible hosts.
It is plain that there are two factors involved in the production of tumours in
animals following the inoculation of tumour cells. The first is the "viability"
of the inoculated cells and the second the "susceptibility" of the host. Serial
dilutions of a suspension of tumour cells may be inoculated into mice and the
proportion developing tumours recorded and plotted against the dose or number
of tumour cells inoculated. The resulting dose-response curve may provide
information concerning the viability of the cells and the susceptibility of the
host animals.
The study of dose-response relationships has received most attention in the
field of pharmacology where the material comprising the dose is not particulate
in the ordinary sense and can theoretically be varied infinitely. In the application
of such studies to viruses, recently reviewed by Isaacs (1957), the dose consists of
a number of virus particles and results have indicated that the appropriate
mathematical distribution is often provided by the Poisson or exponential model.
The purpose ofsome ofthe work on viruses has been to determine what proportion
of particles in a virus suspension are viable and whether a single viable particle
can initiate infection. A difficulty frequently encountered in this field has been to
obtain a reliable method of counting the total (viable and non-viable) number of
particles in a particular preparation. This difficulty does not arise with suspensions
of ascites tumour cells as these are easily counted in a haemocytometer. There-
fore it seemed that a study ofthe dose-response relationship ofan ascites tumour,
along the lines described by virus workers, could provide valuable information
concerning the viability of its constituent cells and should, therefore, be
investigated.
This paper describes the results obtained from the intraperitoneal inoculation
of serial dilutions of Ehrlich ascites tumour cells into a strain of white mice.
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For reasons that will become clear it was found that the methods used here were
not suitable for the direct investigation of the viability of our tumour cells, but
this result is of interest in itself, as is other informationl revealed by our
experiments.
Theoretical introduction
The theoretical considerations which follow are based on the assumption
that a dose-response curve is obtained from observing proportions of animals
responding with tumour following the inoculation of serial dilutions of a suspen-
sion of tumour cells. For the sake of simplicity in this paper animals developing
tumours following the inoculation oftumour cells will be described as having been
"infected ". The term "viability" is used in the sense of the ability of a cell to
infect a completely susceptible host. It will be assumed that tumour cells in
suspension have a Poisson distribution where " a " is the dilution and " m " is
the concentration before dilution.
There appear to be several possible ways in which tumour cells and host
animals may interact:
(a) All tumour cells in a suspension may be viable and may be "autonomous
in the sense that theirgrowth is entirely independent ofhost factors. The animals
may, in fact, be completely susceptible. Ifthis is so, the proportion, P, ofanimals
developing tumours in dilution, a, of a suspension containing m tumour cells
= 1 --e-am
where e-am is the first term of the Poisson series.
Since we may easily estimate the total number of cells inoculated by counting
them, it would be necessary only to compare the observed results with those
calculated to test the validity of this hypothesis. The shape and slope of the
dose response curve will be that of the "one-particle" curve described by Isaacs
(1957) and its position will be determined by m, the number ofcells in the original
suspension.
(b) Only a proportion of the cells in the original suspension may be viable
although the hosts may be completely susceptible.
Let c am be the number of cells in dilution a. If p is the proportion of
viable cells, then
P = 1 - e-CP
The dose response curve would be exactly the same as in (a) except that it would
be shifted to the right. Knowing the total number of cells, it would be an easy
matter to obtain a value forp, provided we knew that the hosts were completely
susceptible.
(c) Hosts may not be completely susceptible, but their susceptibility may be
uniform, when
P = 1 e-cph
where h = the probability that a viable cell will infect a particular host. In this
case the value of h is the same for all mice. The dose-response curve would be
similar to that of (b) and a value for h could only be obtained ifp were known
and vice versa.
(d) More than one viable tumour cell may be required to initiate a tumour,
but the same number of viable cells will initiate tumours in all animals. Let
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g = the number of viable tumour cells producing tumours in all animals, then
P 1 - -cp [1 + cp + (cp)2/2! + ... + (cp)9-1/(g - 1)!]
In this case the slope of the dose response curve would be greater than that dis-
cussed in (a), (b), and (c), and would provide an estimate for g. Knowing this we
could obtain an estimate for p using our knowledge of the total number of cells
inoculated.
(e) The susceptibility ofthe hosts may be variable and
1
P { (1 e-cPh)f (hp) d(hp)
o 0
It this were so it would not be possible to make predictions concerning the dose-
response curve except that in general the slope would be less than those for the
foregoing possibilities. If we could show that the slope were less than the ex-
ponential curves described in (a), (b), and (c) it would be a clear indication that
host susceptibility was variable from animal to animal. Under these circumstance
it would be impossible to reach firm conclusions concerning the viability of the
cells.
(f) A final possibility exists where there may be a combination ofthe situations
described in (d) and (e) where the susceptibility of the hosts may be variable and
more than one viable tumour cell is required to produce a tumour in completely
susceptible hosts. In this case
1
P = e-ChP[1 + chp + (chp)2/2! + ... + (chp)g-1/(g- 1)!]}f(hp) d(hp)
0
Another way ofexpressing this situation would be to imagine that the production
of tumours occurs in two stages. The first stage consists of the implantation of
viable cells and the second stage their growth or progression. Whether or not the
first stage occurred could be governed by the susceptibility of the animals. If
we could detect this stage the probability of its occurrence would be governed
by the equation in (e). However, subsequent growth and progression into a
tumour would occur only when g or more cells had established themselves. This
distribution, however, could not be distinguished from that described in (e).
It follows from the above considerations that it is possible to distinguish
susceptibility of hosts from viability of cells only if the dose-response curves are
those described in (a) or (d).
If the dose-response curve is similar to those in (b), (c), (e), or (f), it will be
impossible to obtain estimates for either susceptibility or viability unless one or
other ofthem is known, as is pointed out by Hoskins, Meynell and Sanders (1956).
However, it would be possible to obtain an estimate of a quantity ca (where
a hp) which is the probability that a cell drawn at random from a preparation
will infect a particular host. Ifhost susceptibility is uniform for all mice, a would
be represented by single value as in (b) and (c), whereas if host-susceptibility is
variable from animal to animal, as in (e) or (f) a would follow a distribution.
Hence, a describes the interaction between a particular group of animals and a
particular preparation of tumour cells. To avoid ambiguity we can speak of the
quantity a as the " sensitivity " of a particular host-cell system remembering that
290DOSE-RESPONSE RELATIONSHIP OF ASCITES TUMOUR
it is the product of the "viability" of the cells and the "susceptibility" of the
hosts.
In examining a dose-response curve of the sort discussed here, the first step
would be to determine whether it departed from the exponential model. In this
work we have applied the method ofprobit analysis as described by Finney (1952).
Armitage and Spicer (1956) have discussed methods for detecting departures from
exponentiality and suggest that probit analysis would be suitable for this purpose
and, as our results show, we have found it so.
MATERIALS AND METHODS
Six experiments were carried out in this series, spread out over the greater
part of two consecutive months.
Animals.-The Institute strain ofpen-bred white mice were used at an age of
between 3 and 4 weeks, within one week of having been weaned. The day before
each experiment, mice obtained from the previous week's weaning were distributed
at random among five groups. Four of the groups were distinguished by being
painted different colours and the remaining group left uncoloured. On the follow-
ing day (the morning of the day of inoculation) each group was distributed at
random, with the restriction that there was only one mouse from each group in
each cage. Twenty mice were used for each dilution of tumour cell suspension in
each experiment. Hence four cages of mice were used for each dilution in each
experiment.
Ascites tumour.-The hyperdiploid line of the Ehrlich ascites tumour was
received from Dr. Hauschka in its 113th ascites generation. In this Institute it
has, except for the first passage, been passed at weekly intervals. The experiments
were carried out on material which had been through at least 35 serial passages
in the Institute strain of mice.
Preparation of turnour cell suspensions.-On the day of each experiment and
within one hour of inoculation, mice inoculated with tumour cells between 5 and
7 days previously were killed, the ascitic fluid removed aseptically and placed in
1 oz. screw-capped bottles. The bottles were placed on a mixer consisting of a
wheel inclined at 45 degrees to the horizontal and rotated at 25 to 30 r.p.m. for
five minutes. After a preliminary count of the tumour cells, some fluid was
removed and diluted so that a final count could be carried out conveniently in a
haemocytometer. At least 200 tumour cells were counted on each occasion.
After the tumour cell concentration had been determined, sufficient Earle's
solution was added so that the concentration of tumour cells was 2 million in
each 0.2 ml. Dilutions for inoculation were prepared from this suspension. In
the first three experiments the suspension containing 2 million cells per 0.2 ml.
and six fourfold dilutions of it (1: 4 to 1: 4,096) were used for inoculation.
In the last three experiments seven twofold dilutions (1: 16 to 1: 1,024) of the
suspension were used.
In the first experiment (Experiment 70) the dilutions were made just before
each one was requiredforinoculation-thus, the originalsuspension was inoculated
and then a 1: 4 dilution was made and inoculated and then a 1:16 dilution
prepared and so on to 1I: 4,096. In the remaining five experiments all dilutions
were prepared before any inoculations were carried out.
The conduct of inoculation.-In the first experiment the mice were inoculated
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in order from the lowest to the highest dilution. In the remaining five experiments
the order in which the cages were inoculated was assigned at random.
A tuberculin syringe (1.0 ml.) full of the appropriate dilution was used for
each cage, each mouse received 0.2 ml. of suspension intraperitoneally by inocu-
lation through the right posterior quadrant of the abdominal wall. A separate
syringe was used for each dilution. The mice in each cage were always inoculated
in the same order, being identified by their colours. Hence, it was possible to
identify mice that had received the first, second, third, etc., doses in the syringe.
Observations of mice.-The mice were examined daily for deaths. Three times
a week they were examined for abdominal swelling, this was recorded as slight,
moderate, or marked. Those mice showing progressive abdominal enlargement
ending in sickness and death were regarded as having "definite ascites " tumours
(" definite ascites" or DA) and no post-mortems were carried out on them.
Other mice dying during the observation period, including those with doubtful
abdominal distension were subjected to post-mortem. Of these, those without
tumour visible to the naked eye were excluded from the subsequent analysis.
Those with tumour visible to the naked eye were recorded as "other tumour"
(OT) mice, except for those with tumour and about 1 ml. or more of peritoneal
fluid which were recorded as "equivocal ascites" (EA) mice. Since mice had
been dead for some unknown number of hours before post-mortem examination,
ifwas often not possible to decide for certain whether small amounts ofperitoneal
fluid were the result of putrefaction or not. In some mice putrefaction was too
advanced for an adequate post-mortem examination and these were excluded
from our final analysis.
The mice were observed for a period of 60 days after which all the survivors
were killed and post-mortem examinations carried out on them. Those without
tumour were recorded as "non-tumour " (NT) mice and included in the analysis.
Those with tumourwere recorded as" other tumour" (OT) or" equivocal ascites"
(EA) as described above and included in the analysis.
Mathematical treatment.-The results of total tumour incidence
[(DA + OT + EA)/(DA + OT + EA + NT)]
in each experiment (Table I) were subjected separately to probit analysis accord-
ing to the method of Finney (1952) and subsequently combined. Probits were
plotted against the logarithm to the base 2 ofthe dilution of the original suspen-
sion. The proportions of definite ascites mice, while neglecting all other tumour
bearing mice [DA/(DA + NT)] (Tables I, II) from all experiments were pooled
and then subjected to probit analysis. Finally, the proportions ofdefinite ascites
mice were considered (Tables I, II) while all other tumour bearing mice and those
without tumours were combined as the non-responding group [DA/(DA + OT
+EA + NT)] (Table II). Note that (DA + OT + EA + NT) "Total mice",
i.e. all mice included in the final analysis.
RESULTS
In the six experiments described here it would have been possible to have
obtained observations on a total of 840 mice. However, of these, 32 were dead
beforeinoculationorwere missing atsome timeduringthecourseoftheexperiments.
In the early stages 97 mice died, mostly within the first week of inoculation,
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TABLE I.-Distribution ofTumrnour Bearing Mice according to DoseofEhrlichAscites
Tumour Cells and Experiments
Totals
A
*Or l
Other +
Experiment numbers
A Definite
70 73 74 82 85 90 ascites
19,0,0 9,3,0 18,0,0 * * * 46
16,0,0 10,32,2 18,0,0 * * * 44
12,11,0 12,0,0 13,3,0 12,21,0 10,31,0 6,31,0 65 ~* * * ~10,42,0 9,5,0 10,71,0 29
9,6,0 5,4;4 11,3,4 7,4,0 8,6,2 8,2,2 48 ~~~* * * ~4,7,2 6,4,1 6,6,2 16
7,41,4 4,52,3 9,41,3 8,4,3 7,6,2 11,3,3 46 ~* - * * ~9,1,2 7,61,2 10,6,3 26
10,2,8 10,2,5 6,3,6 5,0,0 10,2,3 7,21,7 48
4,1,12 8,0,8 6,2,6 * * * 18
equi-
vocal No
tumours tumour
3 0
3(2) 2
12(4) 0
16(3) 0
25 12
17 5
26(4) 18
13(1) 7
11(1) 29
3 26
Grand
total
49
49
77
45
85
38
90
46
88
47
Totals 386 129 99 614
In each group of three figures
(1) The first is the number of" definite ascites" tumours (DA).
(2) The second is the sum of the "other tumours" (OT) and "equivocal ascites" (EA)-
the superscripts indicate the number ofEA included.
(3) The third are those surviving 60 days without tumour (NT).
The figures in brackets among the "Totals" indicate the number of EA included in the total
preceding it.
* = not examined.
TABLE II.-Percentage Incidence of Mice with Tumnours Following Inoculation of
Ehrlich Ascites Tumour Cells: Ratio of Ascites to Non-Ascites Tumours
Per cent tumour incidence
Dilution (DA +OT+ EA) x
100
log2 Total mice
1 100
-1 96
-3 100
-4 100
-5 86
-6 87
-7 80
-8 85
-9 67
-11 45
Definite ascites tumours with
A
1. Non-tumour 2. All other mice
DA DA x100
DA+NT>< Total mice
100 94
96 90
100 84
100 64
80 57
76 42
72 51
79 57
62 55
41 38
· Ratio
Definite ascites/
Other tumours
DA
OT
15-3
44.0
8-1
2-2
1.9
0.9
2.1
2.2
4-8
6*0
The proportions shown in this table are obtained from the figures shown in Table I.
apparently from non-specific causes. During the later stages 159 mice died of
which 79 were subjected to adequate post-mortems and of these 66 showed evi-
dence of tumour growth and included those with equivocal ascites tumours. In
addition, 386 mice showed progressive characteristic abdominal distension fol-
lowed by death and were designated definite ascites tumour mice. In the lowest
dilution progressive abdominal swelling began from 10 to 21 days after inocu-
lation and in the highest dilution from 22 to 40 days after inoculation. Deaths
Dilution
log2
+1
-1
-3
-4
-5
-6
-7
-8
-9
-11
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of these mice occurred 14 to 32 days after inoculation in the lowest dilution and
30 to 49 days after in the highest. The number of mice surviving the observation
period of 60 days was 166 of which 162 was subjected to post-mortem. Of these
63 had evidence of tumour growth and 99 were free of it. Thus, a total of 614
mice provided our observations and the distribution of these is shown in Table I.
Among those mice coming to post-mortem, three types of tumour were ob-
served. Inoculation tumours were those in the abdominal wall at the site ofinocu-
lation. "Soft" tumours were similar to those described for the ascites form of
Sarcoma 37 (Warner, Kroeker and Lederman, 1957) and consisted of friable
whitish tumour material in the substance of tissues. "Hard" tumours were
well-knit firm tumours similar to those obtained by subcutaneous inoculation.
Soft tumours tended to occur relatively soon after inoculation during the
period when mice inoculated with the same number of cells were developing and
dying from definite ascites tumours. Hard tumours tended to occur later than
soft tumours.
Among those 66 mice dying with tumour during the period of observation
approximately half had hard tumour and half soft tumour. Five mice had both
types of tumour simultaneously. Twenty-three of these mice had inoculation
tumours in addition to the other tumours mentioned.
Ofthose mice surviving the observation period of60 days andrevealing tumour
at post-mortem, 49 had hard tumour and two ofthese had soft tumour in addition.
In 14 mice the only evidence of tumour was at the site of inoculation.
Nearly one half of all the hard tumours occurred in the mesentery ofthe small
intestine and approximately one quarter in the region of the pancreas. The
remainder were more or less equally distributed between the regions ofthe kidney,
the internal genital organs and the parietal peritoneum.
Of 34 soft tumours, 16 were in the pancreatic region only, 13 in both the
pancreatic and genital regions and two in the genital region only. The remaining
three were in the region of the kidney.
Fluid of approximately 10 ml. or more was observed in 15 mice, including
two that had survived the observation period. Soft tumour was present in 13 of
the mice with fluid and was accompanied by hard tumour in two instances. In
the remaining two mice fluid was accompanied by hard tumour only.
There was no evidence that the tumour incidence in those mice inoculated
with the first or any other dose in a syringe differed from one another.
The results ofthe probit analysis, based on the proportions ofanimals respond-
ing with any type of tumour (" Total tumours ") show that all six experiments,
carried out at different times, may be represented by a single curve and that
any departures from it may be accounted for by chance alone as is shown in the
Table of Analysis ofX2.
The slope ofthe curve is approximately 0.2 and, by being significantly different
from 2, indicates departure from exponentiality (Armitage and Spicer, 1956).
From these results it is estimated that the number of cells which will produce
tumours in 50 per cent of animals is approximately 850.
The pooled results of all experiments are shown in Fig. 1 and Table II. The
smooth line fitted to the points in circles for total tumour incidence is obtained
from the probit regression equation
Y- 7.33 + 0.21 x
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The exponential curve showing the best fit (Haldane, 1939) to our data is shown
in Fig. 1 as an interrupted line, and it is clear that the observed distribution of
total tumour incidence differs markedly from it.
An analysis of those responding with definite ascites tumours and those
failing to respond at all (i.e. excluding those in the "Other Tumours" column in
Table I) provides a curve of shape and slope similar to that obtained when
tumours of all types are considered. However, the curve is shifted slightly to the
right. The points are not plotted in Fig. 1 for the sake of clarity.
The points in Fig. 1 indicated by solid circles are obtained by regarding
"Definite Ascites" only as the response and including among the non-responders
E 100
2~~~ go~~~~
.80
0.) 60-_-/. /.'
O /
40 _ /
E /
o20 / o2 0-/
o-
~. 0-11 -9 -7 -5 -3 -1 +1
Log2 dilution of suspension containing
two million cells per dose (0-2 ml)
FIG. 1.-Shows the percentage of animals responding with tumours at graded doses of tumour cell
suspension.
O -= Total tumours [(DA+OT+EA)/Total mice]
* = Definite ascites tumours as a proportion of all mice [DA/Total mice].
-= Curve obtained from probit-log dose regression equation.
Curve obtained from Haldane's (1939) maximum likelihood estimation oftheexponential.
those listed as "Other Tumours ", "No Tumours ", and "Equivocal Ascites."
The distribution is considered here firstly to see if it provided evidence that the
ascites response is a completely separate phenomenon from other types oftumour
growth. Secondly, the distribution is somewhat irregular, there being a dip in
the centre. However, the proportion of tumours occurring at the -6 dilution is
not significantly different from the proportion of tumours in the pooled results of
the -7, -8, and -9 dilutions (X2[1 1.3, p =026).
Table II shows the ratios of" definite ascites" tumours to "other tumours"
for each dilution of tumour cell suspension. For the purpose of obtaining these
ratios we have neglected entirely the "Equivocal Ascites" tumours. The ratios
are plotted in Fig. 2 and a curve drawn through them by eye. It will be seen that
the ratio is high in the lowest dilutions and falls to a minimum at dilutions -4,
-5, and -6 which are logarithms to the base 2 of the dilution. Thereafter the
ratio shows a progressive increase as the cells inoculated decrease.PETER WARNER AND A. T. JAMES
=3 0
E
C-
0 c. 0
cn
t
.
Log, dilution of suspension containing
two million cells per dose(02ml.)
FiG. 2.-Shows the ratio of definite ascites tumours to other tumours (DA/OT) at graded doses of
tumour cell suspension. The curve is drawn by eye.
TABLE III.-Analysis ofX2
Degrees of Sum of Mean
freedom squares square
Parallelism of regressions . 5 . 8-374 . 1-675
Residual heterogeneity . 30 . 24.575 . 0-819
Total . . . 35 . 32-949 -
DISCUSSION
The results of the present investigation has shown that the susceptibilities of
the animals used in these experiments are variable and are normally distributed
when plotted against the logarithm of the number of cells inoculated. Hence, in
our animals, the cells of the Ehrlich ascites tumour cannot be called "auto-
nomous" in the sense that they are entirely independent of host-factors. In
consequence of these findings, no conclusions concerning the viability of the
ascites tumour cells can be drawn since it is indistinguishable from host suscepti-
bility. However, we can, as we have shown in our introduction, consider the
quantity a - hp which is the probability of infection of a host by a single cell
and which we have called the "sensitivity" of the host-cell system. This we see
would be variable from host to host and thus is covered by sections (e) and (f)
in the theoretical introduction.
Firstly, dealing with the situation described in (e) we find that the distribution
of the sensitivity can be deduced from the dose-response curve by following the
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"alternative approach" given by Armitage and Spicer (1956). This is most
appropriate here because, as we shall see, the sensitivity distribution must be
approximately log normal.
The probability that a mean dose of c cells will infect a host in a system of
sensitivity a is-
1 e-ca (1)
If the sensitivities are distributed with probability density f(a), then the
probability of infection of a host selected at random is
P= (1 -e-ca)f(a)da
0
0
f(1
-e-ex+Y) (y) dy (2)
--00
where x = log c, y= loga, (y) dy f (a) doc
Define T(y) = 0 for y> 0 and
00
P=f(1 e-ex+v) (y)dy (3)
00
One can see that this is the distribution function of a variate
x= z - y (4)
where z is a variate distributed independently of y with a distribution function
1 e-e (5)
From (4) and independence of z and y, we infer that the mean E[x] and variance
V(x) are given by
E[x] = E[z] - E[y]
V[x] = V[z] + V[y]
hence
E[y] = E[z] - E[x]
V[y] = V(x)- V(z)
Irwin (1942) has studied the distribution of z and shown that
E[z] -- =--0577
V(z)- 72/6 = 1*645
From the fitted probit line we have the estimates for
E[x]: log (2 x 106) - 11.2 loge 2 = 6745
V(x): 23.15 (log6 2)2 = 11 123
Hence the mean and variance of the distribution of the log sensitivities y are
estimated to be
E[y]: -7.322
V(y): 9-478 S.D. 3-079
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Since the probit line fits the data, x is approximately normally distributed.
z is not too far from normal either, and in any case, V(z) is only a small component
of V(x). Thus y must be approximately normal, i.e. we have shown that the
distribution of the log sensitivities is approximately normal, as mentioned earlier.
Our results may be summarized by plotting the distribution of sensitivities
(Fig. 3). For convenience we use a scale of common logarithms, i.e. we plot
3
-
0 C
4)
4)
0
Sensitivity =oc on log scale
FIG. 3.-Frequency distribution of host sensitivities.
- = estimated from the data.
-- by extrapolation.
log10o - y/loge10 *-434 y. E[log10t] - -3'13, S.D. (logl0a) -1'337. The
distribution should be truncated at y _ 0, i.e. at a 1 because we defined that
p(y) 0 for y > 0. As the truncation is slight it makes no appreciable difference
to our estimates of the mean and variance.
Since only the high dosage levels were tested, only the upper half of the dose-
response curve is established. This corresponds to the lower half of the distribu-
tion of h involving those individuals which need large doses for any reasonable
chance of infection. It follows that the lower half of the distribution of h is well
established by the data but the upper half (shown with dots in Fig. 3) is merely
an extrapolation based on the normal fit.
If however, we consider the situation described under (f) in the theoretical
introduction and we replace the formula (1) for the probability of infection by
1 -eCC [1 + ecx + (ca)2/2! + ... + (c)g-lI/(g
- 1)!]
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the theory is the same except that the mean and variance ofz is now
E[z] = y+ (1+1/2 +... +1/(g- 1))
V[z] = r2/6 (1 + 1/22 +-1/32 + . ..+ 1/(g 1)2)
In this model the variance of z is even smaller and thus if it were applicable
instead of (1), y would still be approximately normal.
From our results we can conclude that about 850 cells are required to produce
tumours in 50 per cent of animals. This is of the same order as Hewitt (1953)
found with subcutaneous inoculations of Sarcoma 37 tumour cells. Also, it is
plain from our results, that between one million and two million cells are required
to produce tumours in 99 per cent of animals.
Our experiments did not cover the lower end of the dose-response curve, but
it is interesting to speculate that, ifthe distribution remained the same throughout,
it suggests that one cell would produce tumours in about one to two per cent of
our animals. This would not be at variance with the findings of Hauschka (1953)
who succeeded in producing ascites tumours in about 15 per cent of the more
susceptible suckling mice following the inoculation of single Ehrlich and Krebs
ascites tumour cells. He attributed his proportion of failures only to the lack of
viability of his inoculated cells but it seems probable that host resistance was, at
least in part, a factor.
Another point of interest is the wide variation in sensitivities. About 850
cells are required to infect 50 per cent of mice while about two thousand times as
many are necessary to infect nearly all mice. If we assume that the curve may be
extrapolated towards its lower end we find that 1 to 2 per cent of mice would be
infected by a single cell. It is possible to suggest that genetic incompatibility
between tumour andhost is responsible forthe widespread variation in sensitivities.
However, it is interesting to compare our results with those of Hewitt (1953).
With the number of cells expressed as common logarithms (see Hewitt's Fig. 1)
the standard deviation for his distribution is approximately 1-6 and ours expressed
in the same units, is remarkably close to it being 1.45. Hewitt's Fig. 1 shows that
the standard deviations of the distribution of sensitivities of C3H mice inoculated
with C3H sarcoma is very close to that of Sarcoma 37 and our own. Hence, using
the standard deviation of the distribution of sensitivities as a measure, the quoted
evidence suggests that considerable variation is characteristic of transplantable
mouse tumours and does not appear to be diminished by genetic homogeneity.
The similarity of Hewitt's (1953) results with Sarcoma 37 and ours with the
the Ehrlich tumour is remarkable. Although the two tumours exhibit well-known
differences, another similarity between them is that neither tumour is discrimi-
nating in that each appears to grow in a wide variety of white mice. Both these
tumours are distinguished from the C3H sarcoma grown in the strain of origin
by having a larger ED 50, but show no marked difference in variability.
When we consider the dose-response relationships of ascites tumours only
(Table I and Fig. 1) we see that it is similar to that for all tumours but are shifted
to the right. This suggests that, on the average, a greater number of cells are
required to produce ascites than tissue growth only. In our experience well-
developed Ehrlich ascites tumours always have tissue growth in addition. These
findings give us no reason to think otherwise than that the production of ascites
follows tissue growth if the right conditions are present, and as we have shown
occurs with Sarcoma 37 ascites tumour (Warner, Kroeker and Lederman, 1957).
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Fig. 2 shows the distribution of the ratios of definite ascites tumours to non-
ascites tumours. One might have expected the ratio to have remained constant
where less than 100 per cent of animals respond with tumour. However, this is
obviously not so unless our results represent a freak of chance. We have no simple
explanation for this unexpected distribution. However, we offer the following
tentative and obviously speculative hypothesis.
Let us assume that the development of ascites tumours or solid tumours
depends on two factors: firstly, the number of inoculated tumour cells that
establish themselves in tissues and, secondly, the rate of spread of those tumour
cells where rapid spreading results in the production of ascites. Also let us assume
that a high degree ofsusceptibility in mice is associated with the ability oftumour
cells to spread rapidly in such mice. Although such characteristics would be sub-
ject to a continuous distribution among the mice, the hypothesis can be illustrated
in Table IV where we consider high, medium and low doses of tumour cells,
TABLE IV.-Illustration of Hypothesis to Explain Distribution of Ratios of
Ascites to Non-Ascites Tumours
Definite Other No
Dose ascites tumours tumours
High . Intermediate Resistant
and
susceptible
Medium . Susceptible . Intermediate Resistant
Low . Susceptible . . Resistant
and
intermediate
resistant, susceptible andintermediate mice which develop definite ascites tumours,
other tumours, or no tumours.
The high proportion of ascites tumours at high dosages is due to the large
number of inoculated cells. Where the dose is large enough practically all mice
develop ascites tumours. When the dose is diminished all mice develop tumours
but the resistant ones fail to develop ascites tumours. With medium sized doses
the susceptible mice develop definite ascites, the intermediate other tumours
and the resistant no tumour at all. Low doses fail to cause any kind of tumours
in resistant and intermediate animals-those susceptible mice that are infected
are so susceptible that, once infected, they will allow rapid spread of tumour and
hence the development of ascites. This would account for the high proportion of
ascites tumours following small doses of tumour cells. This explanation finds
some support from the work of Hauschka (1953) who found that, following the
inoculation of single cells into suckling mice, all tumours that developed were
ascites tumours.
SUMMARY
The dose-response curve ofthe Ehrlich ascites tumour in mice was investigated
in an attempt to learn something ofthe viability of tumour cells and the suscepti-
bility of the hosts. The theoretical background of such experiments is discussed.
Six experiments were carried out in which serial dilutions of a suspension of
tumour cells were inoculated intraperitoneally into mice. Observations were
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obtained on a total of 614 mice of which 386 developed typical ascites tumours
and 129 other types of tumour growth.
The results were subjected to probit analysis from which it was concluded
that approximately 850 tumour cells would produce tumours in 50 per cent of
animals and that host susceptibility in the strain of mice used was variable.
Consequently, no conclusion could be drawn concerning the viability of the
tumour cells. However, it was possible to determine the distribution of the log
"sensitivities" of the host-cell system where " sensitivity " is the probability of
infection of an animal by a single cell. It was noted that this distribution was
normal with considerable variance and that its parameters were apparently in
fairly close agreement with those found for Sarcoma 37 by another author. Also
the variance of these tumours was of the same order as a C3H tumour grown in
the strain of origin although their ED 50 was considerably greater. It was con-
cluded that sensitivity ofthese transplantable mouse tumours showed considerable
variation which did not appear to be diminished by genetic homogeneity.
The distribution of the proportions of mice developing ascites tumours did
not appear to be markedly different from that for all types of tumours apart
from a shift to the right.
The ratio of ascites tumours to those without ascites exhibited a curious
distribution when plotted against doses of cells. It was high with high doses,
fell with intermediate doses and then rose again with very low doses. An attempt
was made to provide an explanation for this phenomenon.
It is a pleasure to acknowledge the painstaking technical assistance of Brian
Moore.
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